Beryllium Discovery Corp.
- UEI
- GXKTRC7TLGL7
- CAGE
- 3RWZ9
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- be4.com
- Founded
- 1999
- Employees
- 51-250
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Fragment based inhibitor discovery of the MEP pathway in infectious organisms. | National Institutes of Health | $99,974 | |
| Gene to structure for $10K (GTS10K) | National Institutes of Health | $7,543,270 |
Quick answers
Is Beryllium Discovery Corp. registered in SAM.gov?
Beryllium Discovery Corp.'s SAM.gov registration expired on October 11, 2019.
What is Beryllium Discovery Corp.'s most recent federal award?
Beryllium Discovery Corp.'s most recent federal contract award is Purchase Order HHSN271201600656P, from National Institute on Drug Abuse (NIH), on September 23, 2016.
On GovTribe
See Beryllium Discovery Corp.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors